Market Overview

Raymond James: Bed Bath & Beyond Could Be Unbound After Q2 Report

Raymond James: Bed Bath & Beyond Could Be Unbound After Q2 Report
Related BBBY
55 Biggest Movers From Yesterday
Bed Bath & Beyond Rallies After Q3 Print, But Analysts Aren't Buying It
Bed Bath & Beyond: A Gem For Patient Investors (Seeking Alpha)

Like many of its retail peers, Bed Bath & Beyond Inc. (NASDAQ: BBBY) could post a big beat in second-quarter sales, but that won't necessarily read through to better near-term margins, according to Raymond James. 

The Analyst 

Analyst Budd Bugatch upgraded Bed Bath & Beyond from Underperform to Market Perform.

The Thesis

Bugatch said he anticipates outperformance in same-store sales given a better-than-expected retail environment. (See the analyst's track record here.) 

Despite a projected drop in year-over-year earnings, Bed Bath & Beyond's Sept. 26 quarterly print presents a "trading opportunity" — and nothing more specific than that, Bugatch said. 

“Since a bearish rating now seems too harsh and a constructive rating yet too aggressive, we believe a neutral-type rating is now more appropriate for BBBY — at least until we find the path to an operating profit/margin improvement to be more visible,” the analyst said. 

This is better than the retailer's previous condition, which saw trailing-four-quarter consolidated operating margins compress by more than 1,000 basis points.

“The last five years have been very difficult for Bed Bath’s shareholders; and not much fun for company leaders or board members,” Bugatch said. “While management was focused on transforming Bed Bath by building-out its digital/analytical capabilities and by seeking to become ‘trusted by its customers as the expert for the home and heartfelt life events,’ its efforts came at a high cost.”

Now, with Bed Bath & Beyond guiding for near-term comps growth and diminished declines in operating profit, Raymond James predicts a 2020 bottom to the TFQ operating margin.

Price Action

Bed Bath & Beyond shares were up 5.59 percent at $19.08 at the time of publication Monday.

Related Links:

Analyst: Toys R Us Closures Could Be Positive Catalyst For Bed Bath & Beyond

Bed Bath & Beyond Shares Down, Analysts Chilly After Q3 Report

Photo by Raysonho/Wikimedia. 

Latest Ratings for BBBY

Dec 2018CitigroupMaintainsSellSell
Oct 2018ArgusDowngradesBuyHold
Sep 2018Morgan StanleyMaintainsUnderweightUnderweight

View More Analyst Ratings for BBBY
View the Latest Analyst Ratings

Posted-In: Budd Bugatch retailAnalyst Color Upgrades Analyst Ratings Best of Benzinga


Related Articles (BBBY)

View Comments and Join the Discussion!

Latest Ratings

NLYKeefe Bruyette & WoodsUpgrades10.5
NOCCredit SuisseUpgrades302.0
SHWWells FargoUpgrades475.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Oracle Earnings Preview: Tech Giant Continues Cloud Transition

Trade Winds Keep Blowing, Potentially Putting A Barrier On Rally Chances